Customized Recombinant Protein Production Services Market Size Worth US$8,403.0 Million with a CAGR of 11.4% by 2028 | GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc.,

0

Research and development is the key to the growth of this market. With more money allocated to research in the life sciences, new breakthroughs are being discovered every day. As such, the market for custom recombinant protein production services is expected to continue growing over the next decade. Meanwhile, increasing funding in life sciences is expected to boost the market. For example, the Oxford Protein Production Facility-UK recently received a $3 million grant from the Molecular Biology Laboratory to develop genetically modified models.

The market for custom-made recombinant protein production services is estimated at US$3,958.0 million in 2021 and should present a CAGR of 11.4% during the forecast period (2021-2028).

The growing demand for recombinant proteins is driving the growth of the market over the forecast period.

The prevalence of chronic diseases is high worldwide. The development of new therapies for many chronic diseases such as cancer and other rare diseases is carried out using recombinant proteins and there is an increasing demand for the production of recombinant pharmaceutical proteins in heterologous systems (this is i.e. by introducing either complementary RNA (cRNA) or DNA (cDNA) from one species into cells of another species for expression of the protein of interest). Various uses of recombinant proteins involve complex proteins and glycoproteins that are difficult for biotechnology companies to develop. There is therefore a growing demand for advanced protein production platforms.

𝐓𝐨 𝐌𝐨𝐫𝐞 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 𝐂𝐨𝐩𝐲 https://www.cohherentmarketItinsights.com/insight/request-sample/2737

Technological advancements in the production of recombinant proteins are driving the growth of the market

Technological advancements have supported the development of recombinant protein production, thereby increasing the demand for custom-made recombinant proteins. Moreover, in recent times, many researchers are using microbial cells for the development of recombinant proteins. This factor is expected to propel the growth of the market. For example, according to data published in the NCBI report in December 2019, the microbial cell factory used for the production of recombinant proteins is Bacillus subtilis, particularly those associated with food and food processing. Recent advances in proteomic analysis and genetic manipulation have greatly improved protein production using B. subtilis.

Custom Recombinant Protein Production Services Market – Impact of the Coronavirus (COVID-19) Pandemic

Since the appearance of the COVID-19 virus in December 2019, more than 100 countries around the world have been affected and the World Health Organization announced it as a public health emergency. According to WHO’s weekly COVID-19 epidemiological update, more than 191 million cases and 4.1 million deaths from COVID-19 have been reported up to July 13, 2021 worldwide.

COVID-19 has affected the economy in three main ways; first by affecting production and demand, then by disrupting distribution channels, and finally by the financial impact on companies operating in the market. Due to lockdowns across nations, several countries such as India, China, Saudi Arabia, Egypt, United Arab Emirates and others are facing drug transportation issues. For example, in April 2020, Chinese suppliers halted deliveries to India due to unavailability of manpower, resulting in drug shortages in India.

𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐨𝐟 𝐨𝐟 𝐨𝐟: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarkettinsights.com/insight/request-pdf/2737

Moreover, the players operating in the custom recombinant protein production market are facing crucial challenges on various fronts owing to the COVID-19 pandemic. According to the National Center for Biotechnology Information (NCBI), on April 29, 2020, across the gene and cell therapy industry, preclinical activities and research programs have been disrupted as companies cut the number of people working on the site to ensure their safety. . Around 85% of employees at cell and gene therapy companies work from home for several weeks, which is one of the reasons for the delay in conducting trials. Additionally, lack of personal protective equipment (PPE), laboratory consumables and reagents are other reasons for the delay in conducting clinical trials.

Custom Recombinant Protein Production Services Market: Contention

The high cost of protein expression services is driving the growth of the market. Due to the complex manufacturing process and the need for high quality of recombinant products, the high cost of recombinant proteins is responsible.

Key players

Key Players Operating in the Custom Recombinant Protein Production Services Market GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio , Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO company, LakePharma, Inc., Proteos Inc., Icosagen AS, Novus Biological LLC, ProteoGenix, Premas Biotech, ATUM and Aldevron

𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐅𝐥𝐚𝐭 𝐅𝐥𝐚𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝐎𝐅𝐅 𝐎𝐅𝐅 𝐎𝐅𝐅 𝐎𝐅𝐅 𝐎𝐅𝐅 𝐎𝐅𝐅 𝐎𝐅𝐅 https://www.coherentmarketInsights.com/promo/buynow/2737

Contents

  1. Research objectives and hypotheses
    • Research objectives
    • Hypotheses
    • Abbreviations
  2. Market scope
    • Description of the report
      • Market definition and scope
    • Summary
      • Market Overview, By Expression System
      • Market Snapshot, By End User
      • Market Overview, By Region
    • Consistent Opportunity Map (COM)
  3. Market dynamics, regulation and trend analysis
    • Market dynamics
      • Drivers
      • Constraints
      • Opportunity
    • Impact analysis
    • Regulatory scenario
    • Key developments
    • Comparison in expression system
    • Pricing
    • PEST analysis
  4. Custom Recombinant Protein Production Services Market – Impact of the Coronavirus (COVID-19) Pandemic
    • Government initiatives to combat COVID-19
    • COVID-19 epidemiology
    • Impact of COVID-19 on the supply chain
  5. Custom Recombinant Protein Production Services Market, by Expression System, 2017-2028, (Million US$)
    • introduction
      • Market share analysis, 2021 and 2028 (%)
      • Annual Growth Analysis, 2017 – 2028
      • Industry trends
    • Mammal
      • introduction
      • Market Size & Forecast, and Annual Growth, 2017-2028, (USD Million)
    • bacteria
      • introduction
      • Market Size & Forecast, and Annual Growth, 2017-2028, (USD Million)
    • insect
      • introduction
      • Market size & forecast and annual growth, 2017-2028, (USD Million)
    • Yeast
      • introduction
      • Market size & forecast and annual growth, 2017-2028, (USD Million)
    • Others
      • introduction
      • Market size & forecast and annual growth, 2017-2028, (USD Million)
  6. Custom Recombinant Protein Production Services Market, End User, 2017-2028, (USD Million)
    • introduction
      • Market share analysis, 2021 and 2028 (%)
      • Annual Growth Analysis, 2017 – 2028
      • Industry trends
    • Research institutes
      • introduction
      • Market size & forecast and annual growth, 2017-2028, (USD Million)
    • Biotechnology and pharmaceutical companies
      • introduction
      • Market size & forecast and annual growth, 2017-2028, (USD Million)
    • Contract Research Organization
      • introduction
      • Market size & forecast and annual growth, 2017-2028, (USD Million)
    • Others
      • introduction
      • Market size & forecast and annual growth, 2017-2028, (USD Million)

See press release: https://www.coherentmarketinsights.com/press-release/custom-recombinant-protein-production-services-market-to-surpass-us-67-billion-by-2026-1438

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leading role in providing insight in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Contact us:

Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Share.

About Author

Comments are closed.